UDK: 615.014:616.71-007.234
E. G. Galtsova
Волгоградский государственный медицинский университет, кафедра фармакологии и биофармации факультета усовершенствования врачей
We analyzed prescription drug therapies for the prevention and treatment of osteoporosis in a total of 234 case records of osteoporosis in- and outpatients between 2010 and 2013. We interviewed 397 health care professionals employed in a variety of medical fields in Volgograd and in the Volgograd region to identify the degree of their awareness of prescription drug therapies for the prevention and treatment of osteoporosis. Rheumatologists and endocrinologists appeared to be better informed about prescription drug therapies for the treatment of osteoporosis than any other health care professionals. Gynecologists appeared to be ill-informed. Most often therapeutists and traumatologists prescribe Alpha D3-teva, Miacalcic and calcium supplements to treat osteoporosis, although bisphosphonates are considered to be the first-line therapy for osteoporosis. Prescriptions made by rheumatologists and endocrinologists were consistent with clinical practice guidelines for the treatment of osteoporosis.
osteoporosis, bisphosphonates, preferences of health care professionals, calcium supplements, interviewing, rheumatologists.
Гальцова Екатерина Геннадьевна — аспирант кафедры фармакологии и биофармации ФУВ, Волгоградский государственный медицинский университет, e-mail: kategaltsova@mail.ru